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Cysticercosis is an infection with larval cysts of the cestode Taenia solium. Through pathways that are incompletely understood,
dying parasites initiate a granulomatous reaction that, in the brain, causes seizures. Substance P (SP), a neuropeptide involved in
pain-transmission,contributestoinﬂammationandpreviouslywasdetectedingranulomasassociatedwithdeadT.crassicepscysts.
To determine if SP contributes to granuloma formation, we measured granuloma-size and levels of IL-1β,T N F - α, and IL-6 within
granulomas in T. crassiceps-infected wild type (WT) mice and mice deﬁcient in SP-precursor (SPP) or the SP-receptor (neurokinin
1, NK1). Granuloma volumes of infected SPP- and NK1-knockout mice were reduced by 31 and 36%, respectively, compared to
WT mice (P<. 05 for both) and produced up to 5-fold less IL-1β,T N F - α, and IL-6 protein. Thus, SP signaling contributes to
granuloma development and proinﬂammatory cytokine production in T. crassiceps infection and suggests a potential role for this
mediator in human cystercercosis.
1.Introduction
Neurocysticercosis is the most common parasitic disease
of the central nervous system leading to seizures world-
wide [1]. Humans develop cysticercosis when they ingest
eggs of the tapeworm Taenia solium usually found in
fecal-contaminated water or food [2]. Neurocysticercosis
(NCC) is endemic to many parts of the world [3–7]a n d
is becoming an increasingly important cause of seizures
in the United States due to immigration from Mexico
and Central and South America [8, 9]. Seizures in NCC
most commonly arise as a result of the granulomatous
responses to dead cysts in the brain. The granulomatous
response is associated with production of several cytokines
including T helper 1 (Th1) cytokines such as interferon
gamma (IFN-γ), interleukin-2 (IL-2), and interleukin-12
(IL-12) [10].
T. crassiceps infection in mice is an experimental model
for T. solium cysticercosis in man [11–15]. Intraperitoneal
inoculation with 10 cysts of T. crassiceps results in the entire
peritoneal cavity of the mouse demonstrating granuloma-
tous inﬂammation within 3–6 months. Similar to human
infection, minimal granulomatous inﬂammation is found
surrounding live parasites; rather, granulomatous inﬂam-
mation is initiated when the parasite dies. The mediators
contributing to development of granulomas around the dead
parasite and production of proinﬂammatory cytokines are
not completely understood.
We previously detected substance P (SP) protein within
granulomas associated with T. crassiceps infection [16, 17].
We also demonstrated that levels of IL-2, IFN-γ,I L - 4 ,a n d
IL-10 protein were signiﬁcantly higher in granulomas from
infected WT mice than granulomas from infected SPP-
knockout or the SP-receptor (neurokinin 1, NK1) NK1-
knockout mice [16, 17]. In addition, we detected mRNA
for IL-1α,I L - 1 β,I L - 1r e c e p t o ra n t a g o n i s t ,a n dT N F - α in all
granulomas derived from infected WT mice [18]. However,
corresponding proteins levels were not assessed nor was the
contribution of SP signaling to their mRNA and protein
production and to granuloma formation.2 Journal of Biomedicine and Biotechnology
The current studies were aimed at determining if SP
and NK1 contributed to granuloma development and/or
to production of IL-1β,T N F - α, and IL-6 in cysticercosis.
SP stimulates production of proinﬂammatory cytokines
such as of IL-1β,I L - 6 ,a n dT N F - α by human peripheral
mononuclear cells, bronchial cells, and astrocytes [19–29]
SP also contributes to inﬂammatory processes associated
with other infectious diseases. For example, granulomatous
inﬂammation in murine schistosomiasis requires binding of
SP to NK1 [30]. SP has been demonstrated to stimulate
inﬂammatory cell inﬁltration. SP injection induced recruit-
ment of leukocytes into the pleural cavity of mice and into
the skin of humans [19–29] and stimulated the migration
of human ﬁbroblasts and peripheral blood lymphocytes
in studies using modiﬁed Boyden chambers or micropore
ﬁlter analysis, respectively [19–29]. In the current studies,
we determined granuloma size and measured levels of IL-
1β,T N F - α, and IL-6 protein within granuloma obtained
from T. crassiceps-infected WT and mice deﬁcient in SPP
or NK1. These studies indicate that SP signaling contributes
to granuloma development and proinﬂammatory cytokine
production in T. crassiceps infection and suggests a potential
role for this mediator in human cysticercosis.
2.MaterialsandMethods
2.1. Murine Cysticercosis Model. Female mice were infected
by intraperitoneal inoculation with 10 cysts of the ORF
strain of T. crassiceps, as described in [16, 17]. Three months
following infection, the mice were euthanatized by cervical
dislocation under anesthesia using a combination anesthetic
sacriﬁce rodent cocktail ketamine, 25mg/kg, acepromazine
0.8mg/kg, xylazine 5mg/kg intraperitoneally, at a dose of
0.5–0.7mL/kg intramuscularly. Granulomas associated with
dying cysts were removed from the peritoneal cavity of each
of the infected mice that were euthanized. Three groups
of mice were included in the experiments: (1) wild type
C57BL/6 mice; (2) preprotachykinin or SPP-knockout mice
(Jackson Laborotories, Maine, USA, bred >10 generations
onto the C57BL/6 background); (3) NK1-knockout mice
provided by Dr. Joel Weinstock, Tufts New England Med-
ical Center, Boston, USA, bred >10 generations onto the
C57BL/6 background. Three to 8 infected mice from each
of the 3 groups were used for this study; 4–15 granulomas
per mouse group were used for this study. Granulomas
associated with parasites were identiﬁed visually, removed
from the peritoneal cavity, and either used for quantifying
cytokine proteins by ELISA or used for size determinations.
This study was approved by the Animal Research Committee
at Baylor College of Medicine.
2.2. Granuloma Size Determination. Intact granuloma was
obtained from T. crassiceps-infected WT mice (2 gran-
ulomas), SPP-knockout mice (4 granulomas), and NK1-
knockoutmice(3granulomas),ﬁxedwith4%paraformalde-
hyde, paraﬃn imbedded and completely sectioned by micro-
tome into 7 micron sections. Each section was stained
with giemsa and examined microscopically. The area of
granuloma within each section was measured using Image
J software (NIH). The volume of granuloma within each
section was calculated by multiplying the area times 7
microns and the volume of granuloma within each section
totaled to give the total granuloma volume.
2.3. Sandwich ELISA for the Detection of Cytokines. Cytokine
protein levels were determined in 12–15 granulomas derived
from T. crassiceps infected WT mice, 4–6 granulomas
derived from T. crassiceps infected SPP-knockout mice,
and 9-10 granulomas derived from T. crassiceps-infected
NK1-knockout mice. A portion of each granuloma was
homogenized in PBS, followed by centrifugation at 16,000g.
Total protein in the supernatant was quantitated using the
Bradfordmethod(catno.500-0006,Bio-Rad,Hercules,CA).
IL-1β,I L - 6 ,a n dT N F - α p r o t e i nl e v e l sw e r ed e t e r m i n e db y
sandwich ELISA (R&D Systems, San Diego, California) as
per manufacturer’s instruction. Results are expressed as pg
cytokine/mg total protein.
2.4. Statistical Analysis. Diﬀerences between groups were
compared using Student’s t-test. Signiﬁcance was set at P<
.05.
3. Results
3.1. Granulomas from T. crassiceps-Infected SPP-Knockout and
NK1-Knockout Mice Are Smaller than Granulomas Derived
from Infected WT Mice. To begin to examine the contribu-
tion of SP signaling to granuloma formation in NCC, we
measured granuloma volume in mice with normal and deﬁ-
cient SP signaling. The volumes of granulomas from Taenia
crassiceps infected SPP-knockout mice (1.8 ± 0.45mm2)a n d
NK1-knockoutmice(1.68±0.40mm2)werereducedby31%
and36%,respectively,comparedtogranulomasderivedfrom
infected WT mice (2.62 ± 0.28mm2; P<. 05 for both;
Student’s t-test; see Figure 1).
3.2. IL-1β Protein Levels Are Reduced within Granulomas
from T. crassiceps Infected SPP-Knockout and Infected NK1-
Knockout Mice Compared to Granulomas from Infected WT
Mice. IL-1β is the primary mediator of granuloma forma-
tion in the S. mansoni pulmonary granuloma model [31].
Also, intratracheal injection of agarose beads coupled to
recombinant IL-1β induced pulmonary granulomas in mice
[32]. To determine if decreased production of IL-1β in SPP-
and NK1-knockout mice contributed to reduced granuloma
size in these animals, we measured IL-1β protein levels in
the granulomas derived from each group of mice. IL-1β
p r o t e i nl e v e l si ng r a n u l o m a sf r o mT. crassiceps infected SPP-
knockout mice (216 ± 129ng/mg total protein) and NK1-
knockout mice (101 ± 43ng/mg total protein) were reduced
by 48% and 76%, respectively, compared to granulomas
from infected WT mice (418 ± 278ng/mg total protein;
P<. 05 for both; Student’s t-test; see Figure 2). Thus, SP
signalingcontributestoIL-1βproductionwithingranulomas
formed in response to dying T. crassiceps cysts. Furthermore,
reduced levels of this cytokine likely contributed to reduced
granuloma size in SPP- and NK1-knockout mice.Journal of Biomedicine and Biotechnology 3
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Figure 1: (a) Representative granuloma derived from infected WT,
SPP-knockout, and NK1-knockout mice (white bar=1mm). (b)
Volumes of granulomas derived from Taenia crassiceps infected,
wild type (n = 2) versus SPP-knockout (n = 4) and NK1-knockout
mice (n = 3). Data presented are mean±SD; ∗P<05, size
of infected, SPP-knockout derived granulomas versus WT derived
granulomas, †P<. 05, size of infected, NK1-knockout derived
granulomas versus WT derived granulomas.
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Figure 2: Quantitative levels of IL-1β in granulomas derived from
Taeniacrassicepsinfected,WT(n = 15),SPP-knockoutmice(n = 6)
and NK1-knockout mice (n = 9). Data presented are mean±SEM;
∗P<05,IL-1β levelsininfected,SPP-knockoutderivedgranulomas
versus WT derived granulomas; †P<. 05, IL-1β levels in infected,
NK1-knockoutderivedgranulomasversusWTderivedgranulomas.
3.3. TNF-α Protein Levels Are Decreased within Granulomas
from T. crassiceps Infected SPP-Knockout and Infected NK1-
Knockout Mice Compared to Granulomas from Infected WT
Mice. TNF-α is responsible for granuloma development in
multiple settings. Intratracheal injection of agarose beads
coupled to TNF-α induced pulmonary granulomas in mice
[32]. TNF-α mediates granuloma growth in the S. mansoni
pulmonary granuloma model [31] and is required for
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Figure 3: Quantitative levels of TNF-α in granulomas derived
from Taenia crassiceps infected, WT (n = 13), SPP-knockout mice
(n = 4), and NK1-knockout mice (n = 9). Data presented are
mean±SEM; ∗P<05, TNF-α levels in infected, SPP-knockout
d e r i v e dg r a n u l o m a sv e r s u sW Td e r i v e dg r a n u l o m a s .
granuloma formation in a mouse model of tuberculosis [33].
Similar to our ﬁndings with IL-1β,T N F - α protein levels in
granulomas from T. crassiceps infected SPP-knockout mice
(96±67ng/mgtotalprotein)werereducedby79%compared
to levels in granulomas derived from infected WT mice
(460 ± 452ng/mg total protein; P<. 05; Student’s t-test;
see Figure 3). TNF-α protein levels within granulomas from
NK1-knockout mice (345 ± 153ng/mg total protein) were
decreased by 25% compared to levels with granulomas of
WT mice; however, this diﬀerence did not achieve statistical
signiﬁcance.Thus,SPcontributestoTNF-productionwithin
granulomas formed in response to dying T. crassiceps
cysts. Furthermore, reduced levels of this cytokine likely
contributed to reduced granuloma size in SPP- and, perhaps,
NK1-knockout mice. The failure to detect a signiﬁcant
diﬀerence in TNF-α protein levels between NK1-knockout
and WT mice suggests the possibility that SP-mediated
increases in TNF-α may occur through binding of SP to
other members of the NK family, for example, NK2 or
NK3.
3.4.IL-6LevelsAreDecreasedwithinGranulomasfromT.cras-
siceps Infected SPP-Knockout and Infected NK1-Knockout
Mice Compared to Granulomas from Infected WT Mice. IL-
6 production in human peripheral blood mononuclear cells,
bronchial cells, and astrocytes is increased directly by SP
through the action of nuclear factor IL-6 (NF-IL-6) and p38
MAPK, as well as indirectly in response to IL-1β and TNF-
α through the activation of NF-κB[ 26, 27, 34, 35]. IL-6
mediates its acute proinﬂammatory eﬀects within infected
or injured tissues, in part, through upregulation of CXC
chemokines, which leads to recruitment of the ﬁrst wave
of inﬂammatory cells. As we expected from the IL-1β and
TNF-α results summarized above, IL-6 protein levels in the
granulomas derived from infected SPP-knockout mice (28 ±
30ng/mg total protein) and from infected NK1-knockout
mice (50 ± 16ng/mg total protein) were reduced by 79 and
62%, respectively, compared to levels in granulomas from
infected WT mice (130±153ng/mg total protein; P<. 05 for4 Journal of Biomedicine and Biotechnology
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Figure 4: Quantitative levels of IL-6 in granulomas derived from
Taenia crassiceps infected, WT (n = 12), SPP-knockout mice
(n = 6), and NK1-knockout mice (n = 9). Data presented
are mean±SEM; ∗P<05, IL-6 levels in infected, SPP-knockout
d e r i v e dg r a n u l o m a sv e r s u sW Td e r i v e dg r a n u l o m a s ,†P<. 05, IL-
6 levels in infected, NK1-knockout derived granulomas versus WT
derived granulomas.
both; Student’s t-test; see Figure 4). Thus, SP signaling either
directlyorindirectlythroughtheactionsofIL-1β andTNF-α
contributes to IL-6 production within granulomas formed in
response to dying T. crassiceps cysts.
4. Discussion
The current studies were performed to determine the con-
tribution of SP and its speciﬁc receptor, NK1, to granuloma
development and proinﬂammatory cytokine production
within granulomas arising in mice infected with T. crassiceps.
We demonstrated that the size of granulomas from the T.
crassiceps-infected SPP-knockout mice and infected NK1-
knockout mice were signiﬁcantly smaller than granulomas
from the infected WT mice. Furthermore, proteins levels
of IL-1β, a key mediator of granuloma formation, were
signiﬁcantly lower within granuloma from SPP- and NK1-
knockout mice compared to granuloma from mice. In
addition, compared to granulomas from WT mice, protein
levels of TNF-α, another key mediator of granuloma for-
mation, were signiﬁcantly lower in SPP-knockout mice and
trended in the same direction in NK1-knockout mice. Thus,
SP signaling contributes to granuloma formation, in part,
through induction of IL-1β and TNF-α, key mediators of
granuloma formation.
Substance P and its high aﬃnity receptor, NK1, are
known to play an important role in inﬂammatory responses.
Granuloma formation in response to murine schistosomiasis
requires binding of SP to its speciﬁc receptor [30]. SP is
known to stimulate inﬂammatory cell inﬁltration and to
induce the production of proinﬂammatory cytokines such as
IL-1β,I L - 6 ,a n dT N F - α by human peripheral mononuclear
cells, bronchial cells, or astrocytoma cells [19–29]. Our ﬁnd-
ings extend these observations and indicate that SP signaling
contributes to granuloma formation and production of IL-
1β,T N F - α, and IL-6 protein within granuloma formed
in response to T. crassiceps infection. The mechanism by
which SP stimulates the production of these cytokines may
be by mediating inﬂammatory cell inﬂux [19–24]. Nerves,
endothelial cells, and cells of the immune system produce
SP [36–38]. All of these cells have receptors for SP and are
known to respond to SP [38–40]. SP is known to stimulate
inﬂux of lymphocytes, monocytes, macrophages, and other
immune cells that produce proinﬂammatory cytokines such
as IL-1β,I L - 6 ,a n dT N F - α [19–29]. Although there are
various studies on the molecular mechanisms by which
SP stimulates the production of IL-6 and TNF-α, there
is limited information on the molecular mechanisms by
which SP stimulates IL-1β production. A study by Martin
et al. determined that SP stimulated IL-1 production by
astrocytes via increasing intracellular calcium. These studies
demonstrated that treatment with an intracellular calcium
chelator blocked SP-induced IL-1β production [41]. Other
studies have demonstrated that SP induces TNF-alpha and
IL-6 production through NF kappa B in peritoneal mast
cells [42]. Substance P production of TNF-α in peritoneal
mast cells is also known to be mediated via P38 and JNK
Map kinases [43]. Also IL-6 production in human peripheral
blood mononuclear cells, bronchial cells, and astrocytes is
increased directly by SP through the action of nuclear factor
IL-6 (NF-IL-6) and p38 MAPK [26, 27, 34, 35].
Preprotachykinin protein is cleaved to form two active
neuropeptides, SP and neurokinin A. Therefore, SP pre-
cursor (preprotachykinin) knockout mice produce neither
SP nor neurokinin A. Consequently, our results in SPP-
knockout mice can be attributed to a deﬁciency in either
SP or neurokinin A or both. However, since NK1 binds
only SP and not neurokinin A and the results in NK1-
knockout mice mirror the ﬁndings in SP-knockout mice, we
are conﬁdent in attributing reduced granuloma formation
and proinﬂammatory cytokine production to the absence
of SP signaling and not to reduced or absent neurokinin A
signaling.
In the current studies, we demonstrated that the gran-
uloma size and the levels of the proinﬂammatory cytokine,
IL-1β, are lower in the infected NK1-knockout mice com-
pared to those of the infected SPP-knockout mice. Besides
SP, peptide hormones such as hemokinin can also bind
and activate NK1 at sites of chronic inﬂammation [44].
Therefore, although the current studies suggest that SP
may be an important mediator associated with cytokine
production, there may be other peptide hormones like
hemokinin that also bind and activate the NK1 receptor that
may be associated with granuloma and cytokine production.
Therefore,itmaybepossiblethatintheNK1-knockoutmice,
the synergistic lack of activity of both SP and hemokinin
may have resulted in lower IL-1β levels and granuloma size
as compared to SPP-knockout mice.
Granuloma formation by the host in response to agents
causing chronic infections is thought to be essential for
limiting and eventually clearing infection. However, recent
work in zebra ﬁsh infected with Mycobacterium marinum
suggests that granuloma formation contributes to early
bacterial growth [45]. Intraparenchymal cysts of NCC are
thought to die spontaneously and to elicit a granulomatous
response that does not in itself contribute to the demise ofJournal of Biomedicine and Biotechnology 5
the cyst. Rather, we have previously demonstrated that early
granuloma formed in response to dying cysts contributes
to NCC disease manifestations by producing mediators that
induce seizures [46]. Other groups have demonstrated that
SP is epileptogenic [47]. The current studies demonstrating
that SP signaling contributes to granuloma formation in
Taenia crassiceps infection, together with other published
observations, suggest the possibility that diminishing gran-
uloma formation in NCC by blocking SP, which contributes
togranulomaformationandepileptogenicresponses,maybe
beneﬁcial in the treatment of this disease.
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